Tallahassee Buprenorphine Doctors


Feature Your Practice at the Top of This City Page

Locate Tallahassee buprenorphine and suboxone doctors who specialize in the treatment of opioid addiction.

Ludmila De Faria,
960 Learning Way
Tallahassee, FL 32306
Main Tel: (850) 644-0579
 
 
Dr. Samer Ali, D.O.
1300 Miccosukee Road
Tallahassee, FL 32308
Main Tel: (850) 431-4556
 
 
Dr. Michael Stanley Mitchell, M.D.
1616 Physicians Drive
Tallahassee, FL 32308
Main Tel: (850) 431-5100
 
 
Dr. Peter Claver Debelius-Enemark, M.D.
1616 physicians Drive
Tallahassee, FL 32308
Main Tel: (850) 431-5105
 
 
Dr. Jeffrey Thomas Ferraro, M.D.
1616 Physicians Drive
Tallahassee, FL 32308
Main Tel: (850) 205-0189
 
 



Dr. Sireesha Chimata, M.D.
1616 Physicians Drive
Tallahassee, FL 32308
Main Tel: (850) 431-5105
 
 
Dr. Robert Norman Burns, M.D.
2344 Hansen Lane
Suite 2
Tallahassee, FL 32301
Main Tel: (850) 671-2280
 
 
Dr. Wayne Anthony Sampson,
1381 Cross Creek Circle
Tallahassee, FL 32301
Main Tel: (850) 877-6393
 
 
Dr. Dian A. Picou, M.D.
1615 Mahan Center Boulevard
Tallahassee, FL 32308
Main Tel: (850) 521-5700
 
 
Dr. Mignon Lawson Emenike, M.D.
1965 Capital Circle NE
Tallahassee, FL 32308
Main Tel: (850) 668-5500
 
 
Dr. Krishna Uppu, M.D.
1614 Osprey Point Drive
Tallahassee, FL 32308
Main Tel: (850) 575-5400
 
 

Sublocade Now Available

Sublocade is a newly released medication alternative for treating opioid addiction. It is a product of Indivior, the pharmaceutical company responsible for Suboxone. Sublocade is a once monthly injection of time-released buprenorphine typically provided to patients who have been receiving buprenorphine for at least (7) days and who are stable on their medication. The injection Read More

Posted in Buprenorphine, Medication-Assisted Treatment | Tagged | Leave a comment

Ohio Increases Buprenorphine Access

In 2017, Ohio increased its number of buprenorphine-approved prescribers by 266. This was the result of a $2.3 million dollar Federal grant that provided state-wide training to doctors, nurse practitioners, and physician assistants as reported by Cleveland.com. Historically, Ohio had numerous communities that were underserved with 19 counties having no buprenorphine providers at the beginning Read More

Posted in Addiction Medications, Buprenorphine, Medication-Assisted Treatment, Suboxone | Tagged , | Leave a comment

The Drug Treatment Act of 2000 permitted doctors who meet certain training qualifications to prescribe buprenorphine in the treatment of heroin addiction and other opioid addictions. Buprenorphine physicians became able to assist opioid addicted patients in an office setting bypassing the restrictions that typically apply to patients receiving methadone. This treatment method maximized patient convenience and accessibility thus increasing the number of people who could access medication-assisted treatment (MAT) for opioid addiction.

Buprenorphine is the medication ingredient in Suboxone, Subutex, Zubsolv, Bunavail, and Probuphine that specifically targets opioid withdrawal. Buprenorphine, or "Bup", is the leading pharmaceutical treatment (alongside methadone) for addressing opioid addiction. Both medications are in widescale use throughout the world due to their efficacy in removing the persistent discomfort associated with withdrawal from opiates (ex. runny nose, body ache, anxiety, nausea, diarrhea and other symptoms).

Buprenorphine.US is an information resource for people in search of doctors who specialize in treating opioid addiction with buprenorphine. In recent years, individuals from all age groups and backgrounds have suffered with an unexpected opioid dependency that negatively affected their family relationships, job, finances, and self-esteem. Addiction is a relentless illness, and persistent opiate withdrawal is a particularly difficult medical dilemma. There are presently thousands of U.S. physicians seeking to assist patients ready to address their opioid addiction. Buprenorphine.US is a tool for connecting buprenorphine doctors with new prospective patients wanting specialized primary care for their addictive disorder.